Fragile X study offers new drug hope

September 24, 2012

(Medical Xpress)—An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for autism, according to a study.

Fragile X is a that affects about 1 in 4,000 boys and 1 in 8,000 girls.

It usually results in intellectual impairment and—in many cases—some form of autism.

Brain disorder

In fragile X, a mutation in a gene on the turns off production of a known as FMRP.

This leads to out-of-control activation of the brain chemical glutamate, which plays a key role in learning and memory.

This could help to explain social anxiety and other symptoms of the disorder.

Reducing symptoms

Researchers at the University's Patrick Wild Centre for Autism, and tested a drug known as STX209 in mice that were genetically engineered to have a form of Fragile X.

The team found that it helped correct the biochemical abnormalities associated with the mutation.

This, in turn, reduced seizures and repetitive behaviours in the mice.

The paper has been published in Science Translational Medicine.

"Our paper shows that many of the changes in that are believed to underlie fragile x syndrome can be reversed by this drug. Significant advances are being made in this field and we are hopeful that on-going medical research will make a real difference to the lives of individuals with these conditions. The results are exciting because they show that a drug could help to improve social behaviour in people with fragile x," says Prof Peter Kind, co-director of the Patrick Wild Centre.

In a related study, 46 children and 17 adults with Fragile X were assigned to take the drug for four weeks and a placebo for four weeks.

Patients made bigger improvements on a "social avoidance" scale while they were taking the drug compared with when they were taking the placebo.

The research was conducted by Rush University, the UC Davis MIND Institute and Seaside Therapeutics.

Explore further: New clinical trial to examine medication to treat social withdrawal in Fragile X and autism

Related Stories

Recommended for you

Study links autism severity to genetics, ultrasound

September 1, 2016

For children with autism and a class of genetic disorders, exposure to diagnostic ultrasound in the first trimester of pregnancy is linked to increased autism severity, according to a study by researchers at UW Medicine, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.